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Introduction  and  objectives:  Studies  assessing  the  effects  of  caffeine  (CAF)  on  the  cardiovascu-
lar system  have  demonstrated  that  CAF  can  delay  cardiac  recovery  following  exercise.  This  study
intended  to  assess  the  impact  of  CAF  intake  before  physical  exercise  on  heart  rate  variability
(HRV)  and  cardiovascular  parameters.
Methods:  This  is  a  prospective,  crossover,  controlled  clinical  trial  conducted  at  the  University
of Pernambuco,  Petrolina,  PE,  Brazil.  The  experimental  protocol  was  split  into  three  stages  with
a  minimum  of  48  hours  between  them.  Exercises  intensity  was  standardized  based  on  the  one
repetition  maximum  test  (1RM),  obtaining  the  load  of  each  volunteer  for  the  intensity  of  75%
of  1RM.  In  the  second  and  third  phases,  the  control  protocols  were  applied  and  300  mg  caffeine
was  given  45  minutes  before  training.  HRV  indices  were  determined  at  the  subsequent  times:  0
to  5  minutes  of  rest  (before)  and  during  30  minutes  of  recovery  (Rec)  (after  exercise),  divided
into  six  intervals,  each  of  5  minutes.
Results:  The  final  sample  involved  30  volunteers.  CAF  delayed  HRV  recovery  after  resistance
exercise. In  general,  CAF  impaired  recovery  of  HRV  after  resistance  exercise.  Significant  changes
were  observed  in  the  RMSSD,  SDNN,  TINN,  SD1,  low  frequency  and  high  frequency  indices
between  the  control  and  CAF  group.ponding author.
 address: taisy.cavalcante@upe.br (T.C.F. Cavalcante).
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Conclusion:  CAF  protocol  delayed  parasympathetic  regulation  of  heart  rhythm  following  exer-
cise, slowing  recovery  of  HR,  blood  pressure  and  HRV  indices  after  exercise.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an











Cafeína  retarda  a  recuperação  autonómica  da  frequência  cardíaca  após  o  exercício
de  força  em  indivíduos  saudáveis
Resumo
Introdução  e  objetivos:  Estudos  avaliando  os  efeitos  da  cafeína  (CAF)  sobre  o  sistema  cardio-
vascular mostraram  que  a  CAF  pode  retardar  a  recuperação dos  batimentos  cardíacos  ao  estado
de  repouso  após  o  exercício.  Este  estudo  teve  como  objetivo  avaliar  o  impacto  da  ingestão
de  cafeína  (CAF)  antes  do  exercício  físico  de  força sobre  variabilidade  da  frequência  cardíaca
(VFC)  na  recuperação.
Metodologia:  Trata-se  de  um  ensaio  clínico  prospetivo,  controlado  por  cruzamento,  realizado
na Universidade  de  Pernambuco,  em  Petrolina,  PE.  Está  registrado  no  ClinicalTrials.gov  (Num-
ber  NCT03899675).  O  procedimento  experimental  foi  dividido  em  três  etapas  com  um  mínimo
de  48  horas  entre  elas.  A  intensidade  do  exercício  foi  padronizada  com  base  no  teste  de  1
repetição máxima  (1RM),  obtendo-se  a  carga  de  cada  voluntário  para  a  intensidade  de  75%  de
1RM.  Na  segunda  e  terceira  fase  da  pesquisa,  os  protocolos  de  controle  e  cafeína  (300  mg)
foram  aplicados.  A  ingestão  de  cafeína  aconteceu  45  minutos  antes  do  treinamento.  Os  índices
de  VFC  foram  determinados  nos  seguintes  tempos:  0  a  5  minutos  de  repouso  (antes)  e  durante
30  minutos  de  recuperação (Rec)  (após  o  exercício),  divididos  em  seis  intervalos  de  5  minutos
cada.
Resultados:  A  amostra  final  foi  composta  por  30  voluntários.  No  geral,  a  cafeína  prejudicou  a
recuperação da  VFC  no  período  de  recuperação após  o  exercício  resistido.  Diferenças significa-
tivas  foram  observadas  nos  índices  RMSSD,  SDNN,  TINN,  SD1,  LF  e  HF  entre  o  grupo  controle  e
o  grupo  CAF.
Conclusão:  O  protocolo  CAF  foi  capaz  de  intensificar  reduções  na  atividade  parassimpática  após
o  exercício,  causando  atraso  na  recuperação da  FC,  pressão  arterial  e  índices  de  VFC  após  o
exercício.
©  2021  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Este é  um
artigo  Open  Access  sob  uma  licença CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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of  supplements  by  professional  athletes,  ama-
 recreational  practitioners  of  physical  exercise  has
common  practice,  as  certain  substances  promote
c improvement  and  performance  during  sporting
.1 Caffeine  (CAF)  is  categorized  as  an  alkaloid  xan-
nd  in  isolation  or  added  to  a  wide  variety  of  foods
rages.  It  has  been  extensively  used  in  sporting
s because  of  its  perceived  and  potential  ergogenic
ects  are  due  to  the  blockage  of  adenosine  recep-
 and  A2)  and  increase  in  the  activity  of  the
tic nervous  system  (SNS)  through  the  release  of
amines in  plasma.  At  a  cardiovascular  level,  CAF

















this ing  exercise,  increases  the  time  to  muscle  fatigue
nuates  perceived  exertion.4 It  is,  therefore,  usual
iduals  to  take  CAF  supplements  as  a  strategy  for
rhythm v
non-inva
400training  volume  and  number  of  repetitions  during
s.5--7
logical  deviations  triggered  by  the  combination
nd  physical  exercise  may  not  be  favorable  when
ntation is  used  without  prior  knowledge  of  car-
lar parameters  and  individual  characteristics.8
e,  depending  on  the  CAF  dosage  and  intensity  of
activity,  it  can  become  a  contributing  factor  to
ical difficulties  and  cardiovascular  diseases  (CVD),
rbating  of  the  activity  of  the  SNS  on  the  physical
 specifically  in  individuals  who  have  CVD.3,9
ering  that  the  autonomic  nervous  system  (ANS)
ital  role  in  controlling  blood  pressure  and  heart
),  studying  its  behavior  when  stimulated  makes  it
to  recognize  interventions  or  contributions  of  cer-
tices  during  homeostasis,10 such  as  CAF  intake.11 In
,  we  investigate  the  autonomic  modulation  of  heart
ia  heart  rate  variability  (HRV),  which  is  a  simple  and
sive method  to  assess  neural  control  of  the  heart.12
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s  one  of  the  most  hands-on  techniques  to  analyze
iological  functioning  of  ANS,  both  in  pathological
s and  with  other  variables.  HRV  is  a  variable  that
 the  peak-R  to  peak-R  (RRi)  intervals  of  consecutive
eats.13 Cardiovascular  parameters  for  example  HR,
rterial  pressure  (SAP),  and  diastolic  arterial  pres-
)  are  widely  used  in  cardiovascular  health  and  ANS
14
quently,  this  study  attempts  to  clarify  the  effects
pplementation  prior  to  exercise  on  the  cardiovas-
tem.  More  information  concerning  the  effects  of
he  ANS  triggering  heart  rhythm  disturbances  may
reater  consideration  regarding  the  use  of  these  sup-
 prior  to  training;  so  as  to  avert  injuries  and  the
ce of  CVD  in  subjects  during  resistance  training.
y  sought  to  assess  the  impact  of  CAF  intake  before
exercise  on  HRV  and  cardiovascular  recovery  after
s
T  statement
 conforms  to  the  CONSORT  statement,  we  provided
f  the  study  population  and  background;  subject
 (inclusion/exclusion  criteria);  methods  of  random-
nd  blinding;  description  of  potential  sources  of  bias;
and  safety  measures;  description  of  quantitative
 and  statistical  methods  with  sample  size  defini-
opulation,  inclusion  and  exclusion  criteria
e  healthy,  college-aged  males  were  chosen  for
y.  Subjects  needed  to  have  had  uninterrupted
e training  experience  for  a  minimum  of  three
and  three  or  more  sessions  each  day.  We
 subjects  with  the  following  conditions:  neurolog-
diorespiratory,  musculoskeletal,  endocrine,  renal,
c and  other  related  disease(s)  that  would  prevent
rimental  procedures  from  being  performed,  indi-
ith  resting  systolic  blood  pressure  >130  mmHg  and
iastolic  >90  mmHg,  smokers,  subjects  undergo-
acotherapies,  sedentary  and  inadequately  active
consistent  with  the  International  Physical  Activity
naire.15
xcluded  subjects  who  stated  they  used  anabolic
 Those  who  presented  series  of  RR  intervals  with
%  of  sinus  beats  and  those  who  were  unable  to
 all  stages  of  the  protocols  (Figure  1).
approval  and  informed  consent
 consent  was  signed  by  all  subjects  before  the  tests.

















































fourmmittee  of  University  of  Pernambuco,  Recife,  PE,
umber  3.056.402)  and  were  in  agreement  with  the
 resolution  of  the  National  Health  Council  of  12
r 2012.
subseque
1. Leg  p
2.  Exten
401(2021)  399--406
esign  and  setting
 prospective,  crossover  and  controlled  trial  per-
at  the  University  of  Pernambuco,  Recife,  PE,
he  study  was  registered  with  ClinicalTrials.gov
9675).
ssessment  and  experimental  protocols
and  safety  measures
cols  were  completed  at  two  distinct  times  between
d  21:00  in  a  noiseless  room  with  controlled  temper-
tween  22 ◦C  and  25 ◦C  and  humidity  between  60%
 Subjects  were  instructed  to  avoid  drinking  alco-
rforming  exhaustive  exercise  24  hours  prior  to  the
n and  to  abstain  from  food  or  CAF  drinks  eight  hours
o,  subjects  were  advised  to  eat  only  a  light  meal
rs  prior  to  the  procedures  and  to  wear  comfortable
suitable  for  the  necessary  physical  exertion.
 define  potential  sources  of  bias,  the  descriptive
f  the  subjects  was  defined  to  characterize  the
reduce  the  volatility  of  the  variables,  improving
ibility and  physiological  interpretation.
 the  start  of  the  experimental  procedures,  sub-
re  recognized  according  to  age,  mass  (kg),  height
olic  (mmHg)  and  diastolic  arterial  pressure  (mmHg),
),  abdominal  (cm)  and  hip  (cm)  circumferences,
hip ratio  and  body  mass  index  (BMI).
ental  protocols
rimental  procedure  was  split  into  three  stages  with
m  interval  of  48  hours  between  them,  so  as  to  allow
cts  adequate  recovery  time.  On  the  first  day,  the
exercise  intensity  test  was  performed  based  on  the
,  which  was  completed  before  the  other  stages,  as
cessary  to  prescribe  the  exercise  intensity  in  the
n  the  second  and  third  phase  of  the  research,  the
nd  CAF  protocols  were  performed.  The  subsequent
ere  the  control  and  CAF  protocols  and  the  order
they  were  implemented  was  established  through  a
ation process  involving  the  tossing  of  a  coin.  The
were  blinded  throughout  their  protocol  and  were
ed about  the  order  of  the  protocols
 the  start  of  the  first  stage,  body  weight  measure-
 a  digital  scale  (Welmy,  W200/5,  São  Paulo,  Brazil)
ht  using  a  stadiometer  (ES  2020  -  Sanny,  São  Paulo,
ere  recorded.
ng intensity  was  defined  based  on  the  maximal
wing  the  recommendations  of  the  American  Col-
orts  Medicines’  Guidelines  for  Exercise  Testing  and
ion.16 Subjects  were  coached  to  test  the  load  in  the




C.J.R.  Benjamim,  L.R.L.  Monteiro,  Y.M.d.M.  Pontes  et  al.
Figure  1  Mean  values  and  respective  standard  deviation  of  systolic  arterial  pressure  (A),  diastolic  arterial  pressure  (B)  and  heart
rate  (C)  obtained  in  the  control  and  caffeine  protocols  at  rest  and  during  recovery  (Rec).
Ca:  Caffeine;  Co:  Control;  HR  Peak:  maximum  heart  rate  value  during  exercise.  R1:  5th minute  of  rec;  R2:  10th minute  of  rec;  R3:
15th minute  of  rec;  R4:  20th minute  of  rec  and;  R5:  30th minute  of  rec.
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lysis05  vs.  Rest  in  Control  protocol;  *Ca:  p<0.05  vs.  Rest  in  Caffein
.
tor  chair  and
ting.
bsequent  days  of  data  collection,  the  exercises
formed  based  on  the  load  of  75%  1RM  for  the  afore-
rcises,  based  on  the  load  from  the  test  75%  1RM
y performed,  a  total  of  four  sets  were  completed
aximum  of  10  repetitions  for  each  exercise.
 control  protocol
starting  protocol,  the  HR  monitor  (Polar  RS800CX,
was  positioned  on  the  subjects  to  register  HR  beat-
followed  by  administration  of  a  300  mg  CAF  capsule
cebo;according  to  the  selected  protocol.  We  set
 of  CAF  at  300  mg  as  this  is  considered  safe.  The
0 Dietary  Guidelines  for  Americans  allow  up  to  a
 of  400  mg/day,17 whilst  the  United  States  Food
 Administration  specifies  that  300  mg  is  within  the
 allowed  per  day.18
g  phase:  Initially,  the  subjects  were  seated,  at  rest,
utes,  whilst  recording  HR,  SAP  and  DAP  values  mea-
he  last  minute  of  the  resting  phase.  Similarly,  in  this
RV  indices  were  recorded  for  5  continuous  minutes
rval).
ise: After  these  measurements  the  subjects  per-

























ery  phase:  At  the  end  of  the  activity,  the  subjects
in  located  seated  at  rest,  and  were  observed  for
es.  HR,  SAP  and  DAP  values  were  recorded  within




402tocol;  **Ca:  p<0.05  vs.  R1  in  Caffeine  protocol  (n=30
orded  for  30  minutes  of  recovery  with  six  intervals
utes  each  between  them:  Rec1  (0  to  five  min-
c2  (five  to  10  minutes),  Rec3  (10  to  15  minutes),
 to  20  minutes),  Rec5  (20  to  25  minutes)  and  Rec6
 minutes).’’  To  avoid  measurement  errors  in  the
 parameters,  a single  rater  performed  all  measure-
roughout  the  whole  experiment.
ontrol  phase  was  completed  on  the  second  day  of
n, in  which  subjects  did  not  ingest  CAF.  The  datasets
ected  in  the  standardized  way,  respecting  the  times
ed for  the  analysis  of  cardiac  activity.  Nevertheless,
e  tests  the  subjects  were  questioned  about  the  use
t  the  end  of  the  first  day  of  testing  (control),  sub-
eived  a  capsule  containing  300  mg  of  CAF  and  in
ce with  the  earlier  guidelines,  were  instructed  to
e  capsule  45  minutes  before  the  next  day  of  pro-
iving  the  subjects  adequate  time  for  digestion  and
n of  the  CAF.
ressure
DAP  were  checked  indirectly  using  a  stethoscope
 Classic  II,  Saint  Paul,  USA)  and  aneroid  sphygmo-
ter (Welch  Allyn  Tycos,  New  York,  USA)  placed  on
cts’  left  arm.19
 of  heart  rate  variabilitylysis  was  performed  throughout  the  entire  exper-
protocol  using  an  HR  monitor  (Polar  RS800CX,
 equipment  validated  formerly  to  record  HR.

























































le  1  Mean  values,  followed  by  their  respective
ndard deviations,  minimum  and  maximum  values  of  the
hropometric  variables  and  the  experience  with  exercise.
iables  Mean±SD  Minimum-
maximum
 (years)  23.33±3.15  [19-27]
ight (m)  1.63±4.51  [1.59-
1.96]
ight (kg)  71.14±12.31  [55-97]
I (kg/m2)  23.00±2.75  [17.96-
27.15]
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ecordings  contained  the  required  256  consecutive
 intervals,  which  underwent  digital  filtering  accom-
y  manual  filtering  to  eliminate  artifacts.  Only  series
han  95%  of  sinus  HR  were  included  in  the  study.
of  HRV  linear  methods  in  the  time  domain  and
uency  were  applied.  In  the  time  domain  indexes
ot  of  the  average  of  the  square  of  the  differences
 normal  RR  intervals  adjacent  (RMSSD)  and  standard
 of  the  average  of  all  normal  RR  intervals  (SDNN)
essary.  The  Poincaré  plot  indexes:  standard  devia-
he  instantaneous  rate  variability  the  rhythm  (SD1)
dard  deviation  of  long-term  continuous  RR  inter-
bility  (SD2)and  Geometric  Index:  Triangular  index
d Triangular  interpolation  of  NN  interval  histogram
ere  also  calculated.10
RV  frequency  domain  analysis,  the  spectrum  com-
low  frequency  and  high  frequency,  in  ms2 and  in
ed units,  extracted  using  the  Fast  Fourier  Transform
n &  Tukey,  FFT)  were  used.  The  frequency  bands
 for  each  component  were:  low  frequency  (LF:  0.04
z)  and  high  frequency  (HF:  0.15  to  0.40  Hz).  We
not  to  evaluate  the  LF/HF  ratio  as  it  has  been
rated to  be  theoretically  flawed  and  empirically
ted to  represent  the  sympathovagal  balance.20
nalysis  software  (Kubios  HRV®,  Biosignal  Analysis
ical  Image  Group,  Department  of  Physics,  Univer-
opio,  Finland)21 was  used  to  scrutinize  the  linear
 the  time  and  frequency  domains  and  to  perform
aré  plots.
alysis
be  sample  size,  a  sample  calculation  was  completed
 the  study  by  Gonzaga  et  al.3 considering  the  RMSSD
he  assumed  significant  difference  magnitude  was
n  view  of  a  standard  deviation  of  16.2  ms,  with
k  of  5%  and  beta  of  80%.  A  total  of  28  subjects  were
 for  the  study.
ding  the  data  analysis,  we  enforced  the  descrip-
stics  on  the  characterization  of  the  sample  and  the
ere  reported  as  mean  values,  standard  deviation,
 and  maximum.  Comparisons  of  the  HRV  indices
iovascular  parameters  between  CAF  and  Control
; moments  were  achieved  via  two-way  repeated
s analysis  of  variance.  For  analysis  of  the  moments
sus  recovery),  we  implemented  the  Bonferroni
 for  parametric  distribution  or  post-test  Dunn  for
metric distribution.  Statistical  significance  was  set
 (or  <5%)  throughout.
utations  were  completed  using  Minitab  version
nitab,  PA,  USA),  GraphPad  Instat  version  3.01,  1998
d Software,  Inc.,  San  Diego,  California,  USA)  and
















































REC er,  30  subjects  contributed  to  the  research  study.
lts  of  their  anthropometric  characteristics  and
ce with  physical  strength  training  are  illustrated  in
The R
by CAF  in
a lower  A
interpret
403 BMI: body mass index; kg: kilogram; m:  meter; SD:
 deviation.
ascular  parameters
ot  find  changes  between  the  groups  by  examining
ng  HR,  however,  in  the  CAF  group,  HR  was  supe-
l  recovery  period  intervals.  After  the  5th minute  of
 systolic  blood  pressure  in  the  CAF  cohort  was  found
nificantly  higher  when  compared  to  the  control
AF  vs  Control:  SAP  148.00±15.68  vs  134.00±16.82
 (Figure  1).
ces  between  heart  rate  variability  index
hole,  CAF  impaired  HRV  recovery  after  resistance
 Significant  differences  were  observed  in  the  RMSSD
s.  REC1**  and  REC  5  vs.  REC  2***  p<0.001;  REC  6
**  and  REC  6  vs.  REC2***  p<0.001),  SDNN  (REC  5  vs.
d  REC  5  vs.  REC  2***  p<0.001;  REC  6  vs.  REC1**  and
 REC2***  p<0.001)  (Figure  2),  TINN  (REC  4  vs.  REST*
; REC  6  vs.  REC1**  p<0.0001  and  REC  6  vs.  REC2***
 (Figure  3),  SD1  (REC5  vs.  REC1**  p>0.0001  and  REC
2***  p>0.0001),  SD2  (REC  5  vs.  REST*  p>0.0001;  REC
 1**  p>0.0001  and  REC  5  vs.  REC2***  p>0.0001)  and
 REC  1**  p<0.0001  and  REC  6  vs.  REC  2***  p<0.0001)
),  LF  (REC  5  vs.,  REC1**  p=0.0005  and  REC  5  vs.,
=0.0004)  and  REC  6  vs.  REC1**  p  =  0.004  and  REC  6
 p  =  0.0004),  HF  (REC  6  vs.  REST*  p=0.007)  indices
 the  control  group  and  the  CAF  group.  The  results
udy  indicate  that  CAF  in  combination  with  exercise
can  impair  vagal  recovery  for  a  period  of  30  minutes
).
eduction  is  perceptible  in  the  decrease  of  SDNN,  as
 in  the  CAF  group  even  30  minutes  after  recovery
CAF  similarly  delayed  the  recovery  of  the  frequency
ndices  LF  and  HF,  where  we  found  significant  differ-
tween  the  groups.  Slow  recovery  of  HF  establishes
 delivers  a  reduction  in  parasympathetic  conduction
iod  of  30  minutes  after  exercise  cessation  (Rest  vs.Rtri,  TINN  and  SD2  geometric  indices  were  affected
take  prior  to  exercise,  meaning  that  its  use  enables
NS  adaptation  to  the  stimulus  of  physical  exercise,
ed by  an  overactivity  of  the  sympathetic  response
C.J.R.  Benjamim,  L.R.L.  Monteiro,  Y.M.d.M.  Pontes  et  al.
Figure  2  Mean  values  and  respective  standard  deviations  of  time  domain  HRV  indices  obtained  in  the  control  and  caffeine  protocols
at  rest  and  during  recovery  (Rec).
Ca:  Caffeine;  Co:  Control;  RMSSD:  root-mean  square  of  differences  between  adjacent  normal  RR  intervals  in  a  time  interval;  SDNN:
standard  deviation  of  all  normal  RR  intervals;  ms:  milliseconds;
*Co:  p<0.05  vs.  Rest  in  Control  protocol;  *Ca:  p<0.05  vs.  Rest  in  Caffeine  protocol;  **Co:  p<0.05  vs.  Rec  1  in  Control  protocol;  **Ca:
p<0.05  vs.  R1  in  Caffeine  protocol;  ***Ca:  p<0.05  vs.  Rec  2  in  Caffeine  protocol  (n=30  subjects).
Figure  3  Mean  values  and  respective  standard  deviations  of  geometric  HRV  indices  obtained  in  the  control  and  caffeine  protocols
at  rest  and  during  recovery  (Rec).  Ca:  Caffeine;  Co:  Control;  ms:  milliseconds;  RRTri:  triangular  index;  TINN:  triangular  interpolation
of  RR  interval  histogram;  *Co:  p<0.05  vs  Rest  in  Control  protocol;  *Ca:  p<0.05  vs.  Rest  in  Caffeine  protocol;  **Ca:  p<0.05  vs.  Rec  1
in  Caffeine  protocol;  ***Ca:  p<0.05  vs.  Rec  2  in  Caffeine  protocol  (n=30  subjects).
Figure  4  Mean  values  and  respective  standard  deviations  of  the  Poincaré  HRV  indices  obtained  in  the  control  and  caffeine  protocols
at  rest  and  during  recovery  (Rec).
Ca:  Caffeine;  Co:  Control;  ms:  milliseconds;  SD1:  standard  deviation  of  the  instantaneous  variability  of  the  beat-to-beat  heart  rate;
SD2:  stan  *Co
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showed d
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l redard  deviation  of  long-term  continuous  RR  interval  variability.
ffeine  protocol;  **Co:  p<0.05  vs.  Rec1  in  Control  protocol;  **C
affeine  protocol  (n=30  subjects).
ise.  From  this  viewpoint,  in  the  CAF  group,  TINN
elayed  recovery  until  the  last  moment  (REC  4,  5
he  recovery  of  SD2  in  the  CAF  group  was  late;  this
r was  significantly  reduced  during  the  final  inter-
e  recovery  period  (REC  5  and  REC  6).
ion
lts  confirm  that  ingestion  of  CAF  (300  mg)  before










vagag  recovery  after  exercise;  (b)  delayed  the  recovery
fter  physical  exertion;  (c)  delayed  HR  recovery  to
resting  levels  and  no  significant  deviations  were




Thus, it  
404:  p<0.05  vs.  Rest  in  Control  protocol;  *Ca:  p<0.05  vs.
<0.05  vs.  Rec1  in  Caffeine  protocol;  ***Ca:  p<0.05  vs.
after  strength  exercise  cessation,  we  identified
HF  (REC  6)  of  the  CAF  group  experienced  delayed
 This  emphasizes  that  there  was  a  greater  vagal
al through  exercise  and  preservation  of  the  sym-
drive  in  the  recovery  period  after  exercise.  The
onent  is  reduced  when  the  autonomic  recovery  of
ected.22 In  this  way,  CAF  substantially  affected  the
ic return  of  parasympathetic  activity.
e  time  of  recovery  after  exercise,  CAF  delayed
covery  after  exercise  termination.  We  identified
ults  by  means  of  index  analysis  and  their  respec-
very  moments,  SDNN  (REC  5,  REC6),  TINN  (REC  6),
 5  and  REC  6),  LF  (REC  5  and  REC  6)  and  HF  (REC  6).
was  found  that  CAF  affects  the  recovery  until  the
Revista  Portuguesa  de  Cardiologia  40  (2021)  399--406
Figure  5  Mean  values  and  respective  standard  deviations  of  frequency  domain  HRV  indices  obtained  in  the  control  and  caffeine
protocols  at  rest  and  during  recovery  (Rec).  LF:  low  frequency;  HF:  high  frequency;  ms:  milliseconds;  Ca:  Caffeine;  Co:  Control;
*Co:  p<0.  pro

























































































 the05  vs  Rest  in  Control  protocol;  *Ca:  p<0.05  vs  Rest  in  Caffeine
 Rec1  in  Caffeine  protocol;  ***Ca:  p<0.05  vs  Rec2  in  Caffeine  pr
is  completed  (30  minutes).  Further  studies  have
 that  these  effects  are  also  identified  in  aerobic
3,23
this  in  mind,  the  potential  effects  of  CAF  have
died  for  several  decades  in  various  sports  and  the
d effects  of  CAF  is  the  key  reason  for  its  use  in  recre-
orts.24 Yet,  there  is  currently  a  new  outlook  on  the
 CAF  prior  to  physical  training.  The  effects  of  CAF
ave  been  tested  in  several  sports  modalities  and
.25,26 The  results  described  by  other  studies  applied
 aerobic  exercise  (cycling,  treadmill  test).  Stud-
ntrating  on  HRV  and  CAF  in  advance  of  strength
are  rare  in  the  research  literature.
nfluence  of  CAF  on  HRV  in  strength  exercise  has
een  studied,  but  in  this  case,  CAF  was  adminis-
combination  with  taurine  in  an  energy  beverage.  It
ed  that  taurine  has  antagonistic  effects  on  CAF  and
 this  mechanism,  the  results  are  inconsistent  with
rch  literature.  Although  the  study  did  not  report
ations  in  HRV,  there  was  an  increase  in  HR  before
physical  exercise.27 In  this  study,  we  did  not  detect
t differences  in  resting  HR  between  the  two  groups.
 SAP  was  significantly  higher  in  the  CAF  group.
 physical  activity  blood  pressure  increases  because
d  for  greater  oxygenation  to  permeate  the  tis-
sation  of  physical  exercise  enables  SAP  to  return  to
vels.  Smirmaul  et  al.,28 reported  that  CAF  supple-
n delays  SAP  values  to  the  resting  baseline.  This
s  confirmed  in  this  study;  the  SAP  of  the  CAF  group
ter  at  the  moments  inthe  recovery  period  following
exercise.
cute  response  to  blood  pressure  control  is  medi-
aroceptors.  CAF  seems  to  affect  this  mechanism  by
ing the  permanence  of  high  levels  (>120  mmHg/80
fter  cessation  of  physical  exercise.  Hypertensive
nces were  observed  in  this  study,  after  5  minutes
ry,  in  the  CAF  group.
nalysis  of  CAF’s  effect  on  autonomic  parameters  is
nto  three  moments:  before,  during  and  after  phys-
cise.  At  the  time  before  physical  activity,  some
have  shown  contentious  results  for  the  break-
autonomic  outcomes.  Kliszczewicz  et  al.11 found











































since mg  of  CAF.  Yet,  even  with  300  mg  administered  in
 by  Gonzaga  et  al.3 (2017),  no  significant  changes




405tocol;  **Co:  p<0.05  vs  Rec1  in  Control  protocol;  **Ca:
ol  (n=30  subjects).
ghout exercise,  there  is  a  greater  intensity  of  vagal
al when  CAF  is  ingested.  This  outcome  is  clear,
 an  increase  in  HRpeak,  which  is  explained  in  the
 of  studies  that  assess  HR  during  physical  exercise.
reased  SAP  during  exercise  is  highlighted  with  CAF
This  is  due  to  the  vasoconstriction  caused  by  CAF,
by  the  increased  release  of  catecholamines  into  the
am.
s  scenario,  when  recovering  from  exercise,  CAF
to  affect  the  bradycardic  effect  in  response  to  the
in  blood  pressure,  considering  that  in  the  moments
ry,  both  HR  and  SBP  remain  elevated  for  at  least
s  after  the  end  of  the  exercise.  These  effects  were
 in  the  control  group  (Figure  1).
ggest  that  these  conditions  are  caused  mainly
crease  in  vagal  withdrawal  and  the  amount  of
amines released  into  the  bloodstream  during  exer-
his  scenario,  other  studies  report  that  there  is  an
 release  of  catecholamines  with  CAF  intake29;  and
ng this,  the  greater  the  amount  of  catecholamines
er  the  recovery  of  cardiovascular  activity  after
30,31
 the  study  conducted  by  Gonzaga  et  al.3 assessing
 adult  males  had  similar  outcomes  to  our  own.  The
 of  300  mg  of  CAF  in  combination  with  submaximal
xercise  (65%  to  75%  of  HRmax)  encouraged  a  delay
rasympathetic  reactivation  for  a  period  of  up  to  one
se  results  were  evaluated  by  the  RMSSD,  SD1,  SD2
ffect  was  similarly  clarified  in  the  experiment  by
t et  al.,23 in  which  400  mg  intake  of  CAF  was  shown
vagal  reactivation  after  exercise  for  the  maximum
 minutes),  when  subjects  were  assessed  during  the
 period.  Additionally,  systolic  and  diastolic  blood
s were  higher  than  in  the  control  group.
f  the  major  concerns  that  orients  the  use  of  CAF
ercise  is  its  unselective  use.  Since  CAF  has  thermo-
ects,  it  is  common  for  overweight  or  obese  people
 to  CAF  supplementation  as  a  way  to  heighten
ss.
ffects  of  CAF  on  the  autonomic  and  cardiovascular
rs of  overweight  or  obese  individuals  are  unknown,
 effects  found  in  the  already  completed  studies
ted  in  physically  active  individuals  or  athletes.
in  mind  that  the  neural  adaptation  of  the  their
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